For this, we established stable colon cancer cell lines with KEAP1 knockdown as a model of pure genetic activation of NRF2 and monitored expression levels of thirty NRF2 target genes, which were known from studies with the murine system. This evidence concerns the gene NFE2L2 and malignant colon neoplasm.